A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing three pieces of marijuana research legislation in Congress.

The Michael J. Fox Foundation (MJFF) -- named after the actor, who has Parkinson’s and established the nonprofit -- said last week that lifting barriers to cannabis research, including rescheduling the plant under the Controlled Substances Act (CSA), is necessary to promote studies verifying marijuana’s potential therapeutic benefit for conditions such as Parkinson’s patients.

Click here to read the complete article

Kyle Jaeger ~ MarijuanaMoment.net ~